Maude Tessier, Ph.D.VP, Business Development & Corporate Strategy at Kyn Therapeutics
Dr. Maude Tessier is currently VP, Business Development & Corporate Strategy at Kyn Therapeutics, an Atlas Venture and Orbimed-backed clinical stage oncology biotech company. Maude brings over versatile business development, licensing and alliance management experience in pharma, biotech and academia. Prior to Kyn, she served as Executive Director, Business Development & Licensing at Merck & Co, leading oncology partnering in the Boston Innovation Hub. Previoulsy, Maude was Assistant Director, Business Development and Strategic Initiatives in the Technology and Innovation Development Office at Boston Children’s Hospital. In this role, she forged discovery alliances with industry partners, as well as built and managed the marketing & communications team. Maude began her career at Xanthus Pharmaceuticals, a small venture-backed oncology biotech company in Cambridge, MA, where she had key roles in Business Development, and Program Management of a Phase 3 asset and its eventual FDA approval. Maude is a MassConnect mentor at MassBio and a Board Member for the Brown University Biomedical Innnovation Fund. She holds a B.Sc. in Biochemistry from McGill University and a Ph.D. from the Department of Medical Biophysics at the University of Toronto.